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Abstract:
ART errors are fortunately a rare occurrence. but humans are fallible and mistakes are
inevitable.  As social media sensationalizes these events, we, as infertility specialists,
must be vigilant in reviewing existing risk management systems and consider other
options to minimize/eliminate these events.  ART programs should work emphasize
honesty and transparency to improve quality of care.
Consider This:
Given the recent flurry of sensational “mix-ups” involving IVF (in vitro fertilization) and
IUI (intrauterine insemination), public trust in the field of assisted reproductive
technology (ART) has undoubtedly been shaken. None of these acts are comforting; some
display human error, and others are outright egregious. While human error is a constant
variable in any facet of medicine, recent reports involving misplaced embryos; the failure
of cryopreservation tanks that destroyed more than 4,000 oocytes and embryos, and the
use of  erroneous gamete/embryo transfers.do not appear to be simple mistakes.1-5  To
further exacerbate patient outrage, several physicians  have been accused of inseminating
patients using their own sperm or sperm from a hospital employee instead of the intended
father without informing their patients.6,7 
Most of us are overcome with horror and profound disappointment when we hear of these
events. At best, these incidents suggest major disregard for protocol; at worst, they hint at
outright deception, rather than simply confusing sperm samples that are being
simultaneously processed in the laboratory. These missteps strike fear into the hearts of
reproductive physicians and scientists, the vast majority of whom dedicate their careers to
avoiding such errors.
Furthermore, these acts inspire news stories that cause patients to be distrustful of ART
services and providers. Yet our cognitive biases predispose us as physicians and staff to
perceive that we could never commit such acts, intentionally or unintentionally. Thus, as
professionals, we are compelled to address these incidents through a “warts and all”
approach.
Since the birth of birth of Louise Brown, now over 40 years ago, more than one in 10
women end up seeking fertility-related services from 480 U.S. clinics, resulting in 69,000
IVF live births a year – nearly 2 percent of all children born annually. More complex IVF
procedures have evolved, including micromanipulation and pre-implantation genetic
testing (PGT), cryopreservation of eggs and embryos, and non-traditional family units
including not only intended parents but also egg and sperm donors and gestational
carriers.  Furthermore, IVF requires the involvement of medical, nursing, paramedical
staff, ultrasonography, and embryology, and has an ever-expanding volume of cases.
Current estimates posit that the number of ART cycles reported on the Society of Assisted
Reproductive Technology (“SART”) website (http://sart.org) have doubled between 2003
and 2017.
Over the years, this has led fertility clinics to adopt stringent control measures to
minimize errors and ensure that ART practitioners meet the standard of care, with the goal
of ensuring optimal care for infertility patients.   The impact of errors, or non-
conformances, in laboratory medicine has a reported range from 2.7% to 12%.8 More
recently, Sakkas et al. reported non-conformance rates were significantly lower. Out of
over 36,000 fresh and frozen IVF cycles involving almost 182,000 laboratory procedures,
99.9% of procedures proceeded with no errors. Moreover, they observed no major grade
non-conformances, errors with an extreme patient impact, such as a confirmed pregnancy
or birth following misidentification of sperm, egg or embryo, or a tank failure affecting
multiple patients.9 Letterie reported on medical malpractice claims from a single carrier
covering 10 of the roughly 480 ART practices in the U.S. between 2006 and 2015. While
claims were rare (0.00095%, 176 in 184,015 IVF cycles), misdiagnosis and lack of
informed consent accounted for 76% of award dollars, but errors in handling of embryos
were most frequent, accounting for 38% percent of claims paid.10
Despite these rare major grade non-conformances, some have questioned whether there is
enough oversight in the ART industry. Attorneys specializing in reproductive medicine
malpractice have deemed this field the ‘Wild West’ of medicine—a realm where almost
anything goes and almost no one knows what has gone on.” 11   Arguments point out that,
while these mistakes are tracked and publicly reported in other fields of medicine, there is
no mechanism for reporting them in ART.
But reproductive medicine has adopted stringent control measures. Oversight frameworks
were passed in 1992, when Congress passed the Fertility Clinic Success Rate and
Certification Act (FCSRCA) mandating standard definitions and reporting of ART cycle
data to the Centers for Disease Control and Prevention (CDC).12  This information is used
to generate an annual report from individual and aggregated clinics on infertility
procedures and their success rates to provide greater disclosure. As a result of FCSRCA,
the CDC developed a model program for certifying embryology laboratories in 1999,
including requirements for a state continuing certification program, quality assurance and
control standards, an inspection system, and conditions under which certification can be
suspended or revoked.  In 2005, the FDA assumed comprehensive jurisdiction over
screening and testing of reproductive tissues, such as the eggs and sperm that will be
transferred into human recipients.13  Agency regulations mandate strict protocols for egg
and sperm donors, including thorough medical histories, identification controls, freedom
from infectious diseases, and rigorous inspection of the facilities in which these tissues
are handled. 
Today, regulations, inspections, and guidelines all help to ensure that ART practitioners
uphold standards of care.  ASRM (http://asrm.org) describes the field of ART as “one of
the most highly regulated of all medical practices in the U.S.” The College of American
Pathologists (CAP) accreditation program ensures that reproductive laboratories conform
to high national standards of quality. On the federal level, three agencies regulate ART,
including the CDC, the FDA, and the Centers for Medicare and Medicaid Services.14 
Additionally, ASRM’s affiliate, SART, strictly monitors member clinics for adherence to
ASRM guidelines, accreditation of their embryology labs, qualification of their staff, and
submission of data to the CDC to ensure that reproductive laboratories conform to
national standards. ASRM and SART also continually establish and revise ethical and
practice guidelines and membership requirements, including guidelines on minimal
standards for providing ART.15
Fortunately, adverse events leading to death are extremely rare in our medical specialty.
However, in our industry, the most egregious harms are when gametes/embryos are given
to the wrong patients during a reproductive treatment cycle or when reproductive tissue is
inadvertently destroyed.16 These incidents can have significant emotional, psychological,
relational, and legal ramifications.
Although the vast majority of physicians and scientists possess the utmost integrity
(unlike those who purposefully use others’ gametes without the consent of progenitor or
recipient),  we must acknowledge that such errors are possible in our industry.17  While
these severe non-conformances are generally not fatal, they cause immeasurable
psychological distress and lead to highly publicized events, including embryo
misidentifications leading to a child’s birth from different genetic parents, or gametes or
embryos that are inadvertently destroyed.  
So what more can be done to eliminate these incidents? Various professionals have
suggested additional precautions, including enhanced quality assurance (QA) initiatives,
modifications in laboratory staffing, biologic labelling, and perhaps a transparent public
ranking system.
With respect to QA, Quality Management Systems (QMS), including the IOS 900,
utilized in business organizations, have been implemented in the arena of ART programs. 
Alper has reported on the utilization of a QMS ISO 9001:2008 system (now a newer
version ISO 9001:2015) that was adapted to an ART program.18  These QMS systems
allow practitioners to control documents, clearly delineate staff member responsibilities ,
document numerous processes and procedures, improve error tracking and reduction, and
exercise better systems control.  Most importantly, practitioners have suggested that QMS
systems can provide transparency within the organization and promote continual
improvement. Perhaps national implementation of these systems will, as Alper suggests,
“encourage data-driven decisions as opposed to emotional ones, will have (internal)
metrics to prove it…other than pregnancy rates.”
There continues to be dramatic changes in ART practice including increasing numbers of
ART procedures, use of embryo “freeze-all,” and pre-implantation genetic testing.  As
such, safe and efficient operation of the ART laboratory has become increasingly
complex, including the myriad  responsibilities associated with maintaining proficiency
and documentation. Alikani et al. reported that the time required to complete a
contemporary ART cycle has increased significantly, requiring up to 20.2 person hours as
compared with the same requirements for the ‘‘traditional cycle’’ of the 1980s and 1990s
(roughly 9.1 person hours).19  Today’s ART cycles take longer because they involve more
complex technologies and have more procedural steps with suggested laboratory
witnessing requirements. Moreover, although guidelines suggest that safe and efficient
ART laboratory operation requires one embryologist for every 90 –150 ART cycles per
year,20,21 estimates suggest that this falls short of the average recommended staffing,
introducing additional risks.22 Perhaps it is also necessary to implement strict workloads,
reducing each laboratory staff member’s hours to include mandatory work breaks. At a
minimum, each clinic should assess its staff numbers, work volume, and ratio of senior to
junior embryologists to determine appropriate staffing.  Alikani et al. have proposed an
interactive Personnel Calculator to better help determine staffing needs.19. Interestingly,
Boone and Higden have described “typical” and “optimal” work environments for ART
facilities, and suggest the CDC should add annual survey questions to compare time and
staffing requirements to pregnancy and live-birth rates. Perhaps such measures as these
could also lead to greater transparency and appropriate workload allocation.23
Outside of personnel matters, proper reproductive sample identification is fundamental to
eliminate the risk of gamete and embryo mismatches.  Labeling all labware and
implementing manual double witnessing or electronic witnessing protocols, undoubtedly
minimizes the risk of sample mismatching due to human error.  WGA biofunctionalized
barcodes have been used to identify mouse and human embryos so long as it does not
significantly affect embryo preimplantation developmental and quality;24,25 previous
studies have clearly demonstrated no effect on full-term development in mice; however,
the potential effects on human embryo implantation and post-implantation development is
undetermined.  Cell labeling with dyes or retroviral vectors in mouse embryos has yielded
important information about the embryonic origin of cell lineages, and could possibly
serve as an appropriate identification method.26. Genetic fingerprinting may also prove an
important tool given a suspected incorrect embryo transfer; fetal genotypes could be
compared to the pre-screened genotypes of the appropriate embryo cohort.27
Improvements in cryotank malfunction and troubleshooting are also necessary. Some tank
alert systems feature a scale underneath each tank to monitor weight changes and detect
issues with the liquid nitrogen. Others use online platforms giving staff real-time access to
cryogenic tank temperature. Creating mandatory industry standards would help prevent
such catastrophies.  
Our intent in this piece is not to focus on the willful failure to disclose medical errors or
knowingly misusing embryos or gametes, but on the medical (human) risk of error that is
present in all medical fields. How we handle these errors matters enormously. Simply
acknowledging errors and how they occur can spur identification of solutions.  Admitting
mistakes is devastating to both the patient and the IVF team, but our patients’ safety and
outcomes are the highest priority. To paraphrase Proverbs 16:18, “pride makes excuses,
and humility makes adjustments.” Thus, we must continue and adjust risk management
strategies to ensure that we continue to deserve patients’ trust. Consequently, a publicly
accessible clinic rating system based on adherence to error reduction and patient safety
measures could provide patients valuable data.
Patients clearly deserve better. Entrusting one’s gametes or embryos to laboratory
personnel can be a fearful process. Though incidence rates are extremely low, news of
these errors may prompt already stressed infertility patients to discontinue treatments that
are highly likely to succeed. We as an industry must improve our self-regulation and
monitor compliance with legal, ethical, and safety standards. Errors must be immediately
disclosed to patients, and practitioners must immediately apologize and seek a
resolution.9 No error can be undone, but early disclosure will build trust, strengthen
patient-provider relationships, and likely decrease malpractice claims. Lack of
transparency invites independent parties, including governmental regulators and tort
lawyers, into clinics to monitor and enforce standards.  Only through acknowledging that
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